Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Anal abscess | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Anal incontinence | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Atelectasis | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Atrial flutter | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Axillary mass | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Bone pain | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Burning sensation | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Cardio-respiratory arrest | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Cellulitis | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Chest pain | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Chondrocalcinosis pyrophosphate | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Cough | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Disease progression | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Diverticulitis | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Drug intolerance | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | General physical health deterioration | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Haemorrhoids | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Heart rate increased | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Hyperlipidaemia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Inappropriate antidiuretic hormone secretion | 1 |
Total Records: 1,104 Number of Pages: 56